These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 15386341)

  • 1. Epoetin alfa improves quality of life in patients with cancer: results of metaanalysis.
    Jones M; Schenkel B; Just J; Fallowfield L
    Cancer; 2004 Oct; 101(8):1720-32. PubMed ID: 15386341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy.
    Quirt I; Robeson C; Lau CY; Kovacs M; Burdette-Radoux S; Dolan S; Tang SC; McKenzie M; Couture F;
    J Clin Oncol; 2001 Nov; 19(21):4126-34. PubMed ID: 11689580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population.
    Cella D; Zagari MJ; Vandoros C; Gagnon DD; Hurtz HJ; Nortier JW
    J Clin Oncol; 2003 Jan; 21(2):366-73. PubMed ID: 12525531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N; Sriuranpong V; Suwanrusme H
    J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trial.
    Pronzato P; Cortesi E; van der Rijt CC; Bols A; Moreno-Nogueira JA; de Oliveira CF; Barrett-Lee P; Ostler PJ; Rosso R;
    Oncologist; 2010; 15(9):935-43. PubMed ID: 20798194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life.
    Hudis CA; Vogel CL; Gralow JR; Williams D;
    Clin Breast Cancer; 2005 Jun; 6(2):132-42. PubMed ID: 16001991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of epoetin alfa in chemotherapy patients: a consistent profile of efficacy and safety.
    Itri LM
    Semin Oncol; 2002 Jun; 29(3 Suppl 8):81-7. PubMed ID: 12082659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy.
    Littlewood TJ; Nortier J; Rapoport B; Pawlicki M; de Wasch G; Vercammen E; Schuette W; Wils J; Freund M;
    Hematol Oncol; 2003 Dec; 21(4):169-80. PubMed ID: 14735555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.
    Littlewood TJ; Bajetta E; Nortier JW; Vercammen E; Rapoport B;
    J Clin Oncol; 2001 Jun; 19(11):2865-74. PubMed ID: 11387359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of quality of life in a clinical trial with nonrandom dropout: the effect of epoetin alfa in anemic cancer patients.
    Fairclough DL; Gagnon DD; Zagari MJ; Marschner N; Dicato M;
    Qual Life Res; 2003 Dec; 12(8):1013-27. PubMed ID: 14651419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.
    O'Shaughnessy JA; Vukelja SJ; Holmes FA; Savin M; Jones M; Royall D; George M; Von Hoff D
    Clin Breast Cancer; 2005 Feb; 5(6):439-46. PubMed ID: 15748464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum- and nonplatinum-based chemotherapy: a retrospective subanalysis of two large, community-based trials.
    Glaspy J; Degos L; Dicato M; Demetri GD
    Oncologist; 2002; 7(2):126-35. PubMed ID: 11961196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of epoetin alfa on quality of life during cancer chemotherapy: a fresh look at an old problem.
    Glaspy J
    Semin Hematol; 1997 Jul; 34(3 Suppl 2):20-6. PubMed ID: 9253780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of erythropoietin-stimulating agents in breast cancer patients: a risk review.
    Crouch Z; DeSantis ER
    Am J Health Syst Pharm; 2009 Jul; 66(13):1180-5. PubMed ID: 19535656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epoetin alfa therapy for patients with hematologic malignancies and mild anemia.
    Straus DJ
    Clin Lymphoma; 2003 Aug; 4 Suppl 1():S13-7. PubMed ID: 14556671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.
    Afdhal NH; Dieterich DT; Pockros PJ; Schiff ER; Shiffman ML; Sulkowski MS; Wright T; Younossi Z; Goon BL; Tang KL; Bowers PJ;
    Gastroenterology; 2004 May; 126(5):1302-11. PubMed ID: 15131791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epoetin alfa in patients not on chemotherapy - Canadian data.
    Quirt I; Robeson C; Lau CY; Kovacs M; Burdette-Radoux S; Dolan S; Tang SC; McKenzie M; Couture F
    Semin Oncol; 2002 Jun; 29(3 Suppl 8):75-80. PubMed ID: 12082658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management.
    Couture F; Turner AR; Melosky B; Xiu L; Plante RK; Lau CY; Quirt I
    Oncologist; 2005 Jan; 10(1):63-71. PubMed ID: 15632253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of Epoetin alfa on quality of life in anemic cancer patients.
    Cella D; Bron D
    Cancer Pract; 1999; 7(4):177-82. PubMed ID: 10687582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.